Floatz logo

vc004

Locally Advanced Solid Tumor

Jiangsu vcare pharmaceutical technology co., LTDPhase 3Active
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
81/ 100

Competitive context

53 Active assets in the Locally Advanced Solid Tumor cohort.

Asset / SponsorPhaseRating
Nivolumab
Mohammed Milhem
Phase 2B
Eloxatin
Parabilis Medicines, Inc.
Phase 2B
TRASTUZUMAB
Aiping Zhou
Phase 2B
Cetrelimab
University Medical Center Groningen
Phase 2CCC
Pembrolizumab
Mohammed Milhem
Phase 1/2CCC

View all 50 →

Same molecule, other indications

vc004 is also rated in:

metastatic neoplasmDormant
CC
Indicative ·
47 / 100
View asset →
Metastatic Solid TumorDormant
CC
Indicative ·
41 / 100
View asset →
NTRK fusion positive cancerDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →